Genfit S.A. (EPA:GNFT)
France · Delayed Price · Currency is EUR 7.88
-0.26 (-3.19%)
At close: Feb 20, 2026
Genfit Market Cap
Genfit has a market cap or net worth of €392.39 million as of February 20, 2026. Its market cap has increased by 103.33% in one year.
Market Cap
392.39M
Enterprise Value
423.79M
Revenue
45.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
€7.88
Market Cap Chart
Since December 20, 2006, Genfit's market cap has increased from 146.07M to 392.39M, an increase of 168.63%. That is a compound annual growth rate of 5.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 392.39M | 49.67% |
| Dec 31, 2025 | 262.17M | 48.73% |
| Dec 31, 2024 | 176.27M | 0.17% |
| Dec 29, 2023 | 175.98M | -10.69% |
| Dec 30, 2022 | 197.03M | -8.19% |
| Dec 31, 2021 | 214.62M | 38.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DBV Technologies | 1.08B |
| Inventiva | 1.07B |
| Nanobiotix | 1.06B |
| Valneva SE | 825.33M |
| MedinCell | 790.50M |
| Cellectis | 248.80M |
| Transgene | 225.09M |
| MaaT Pharma | 138.87M |